BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32738630)

  • 1. Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer.
    Mo H; Wang X; Ma F; Qian Z; Sun X; Yi Z; Guan X; Li L; Liu B; Xu B
    Breast; 2020 Oct; 53():111-118. PubMed ID: 32738630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
    Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
    Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High chromosome instability identified by low-pass whole-genome sequencing assay is associated with TP53 copy loss and worse prognosis in BRCA1 germline mutation breast cancer.
    Zhu L; Pan JN; Qian Z; Ye WW; Wang XJ; Cao WM
    Breast Cancer; 2022 Jan; 29(1):103-113. PubMed ID: 34403063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centromere 17 copy number gain reflects chromosomal instability in breast cancer.
    Lee K; Kim HJ; Jang MH; Lee S; Ahn S; Park SY
    Sci Rep; 2019 Nov; 9(1):17968. PubMed ID: 31784614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.
    Gogas H; Kotoula V; Alexopoulou Z; Christodoulou C; Kostopoulos I; Bobos M; Raptou G; Charalambous E; Tsolaki E; Xanthakis I; Pentheroudakis G; Koutras A; Bafaloukos D; Papakostas P; Aravantinos G; Psyrri A; Petraki K; Kalogeras KT; Pectasides D; Fountzilas G
    J Transl Med; 2016 May; 14(1):136. PubMed ID: 27184134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landscape of Chromosome Instability in Breast Cancers and Associations with the Tumor Mutation Burden: An Analysis of Data from TCGA.
    Voutsadakis IA
    Cancer Invest; 2021 Jan; 39(1):25-38. PubMed ID: 33306412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potential.
    Miller ET; You S; Cadaneanu RM; Kim M; Yoon J; Liu ST; Li X; Kwan L; Hodge J; Quist MJ; Grasso CS; Lewis MS; Knudsen BS; Freeman MR; Garraway IP
    BMC Cancer; 2020 May; 20(1):398. PubMed ID: 32380981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes.
    Smid M; Hoes M; Sieuwerts AM; Sleijfer S; Zhang Y; Wang Y; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2011 Jul; 128(1):23-30. PubMed ID: 20632083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.
    Stover DG; Parsons HA; Ha G; Freeman SS; Barry WT; Guo H; Choudhury AD; Gydush G; Reed SC; Rhoades J; Rotem D; Hughes ME; Dillon DA; Partridge AH; Wagle N; Krop IE; Getz G; Golub TR; Love JC; Winer EP; Tolaney SM; Lin NU; Adalsteinsson VA
    J Clin Oncol; 2018 Feb; 36(6):543-553. PubMed ID: 29298117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal instability selects gene copy-number variants encoding core regulators of proliferation in ER+ breast cancer.
    Endesfelder D; Burrell R; Kanu N; McGranahan N; Howell M; Parker PJ; Downward J; Swanton C; Kschischo M
    Cancer Res; 2014 Sep; 74(17):4853-4863. PubMed ID: 24970479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide single-nucleotide polymorphism arrays in endometrial carcinomas associate extensive chromosomal instability with poor prognosis and unveil frequent chromosomal imbalances involved in the PI3-kinase pathway.
    Murayama-Hosokawa S; Oda K; Nakagawa S; Ishikawa S; Yamamoto S; Shoji K; Ikeda Y; Uehara Y; Fukayama M; McCormick F; Yano T; Taketani Y; Aburatani H
    Oncogene; 2010 Apr; 29(13):1897-908. PubMed ID: 20062086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
    Oh CR; Kong SY; Im HS; Kim HJ; Kim MK; Yoon KA; Cho EH; Jang JH; Lee J; Kang J; Park SR; Ryoo BY
    BMC Cancer; 2019 Apr; 19(1):292. PubMed ID: 30935424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of extreme chromosomal instability with long-term survival in a retrospective analysis of primary breast cancer.
    Roylance R; Endesfelder D; Gorman P; Burrell RA; Sander J; Tomlinson I; Hanby AM; Speirs V; Richardson AL; Birkbak NJ; Eklund AC; Downward J; Kschischo M; Szallasi Z; Swanton C
    Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2183-94. PubMed ID: 21784954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
    Adalsteinsson VA; Ha G; Freeman SS; Choudhury AD; Stover DG; Parsons HA; Gydush G; Reed SC; Rotem D; Rhoades J; Loginov D; Livitz D; Rosebrock D; Leshchiner I; Kim J; Stewart C; Rosenberg M; Francis JM; Zhang CZ; Cohen O; Oh C; Ding H; Polak P; Lloyd M; Mahmud S; Helvie K; Merrill MS; Santiago RA; O'Connor EP; Jeong SH; Leeson R; Barry RM; Kramkowski JF; Zhang Z; Polacek L; Lohr JG; Schleicher M; Lipscomb E; Saltzman A; Oliver NM; Marini L; Waks AG; Harshman LC; Tolaney SM; Van Allen EM; Winer EP; Lin NU; Nakabayashi M; Taplin ME; Johannessen CM; Garraway LA; Golub TR; Boehm JS; Wagle N; Getz G; Love JC; Meyerson M
    Nat Commun; 2017 Nov; 8(1):1324. PubMed ID: 29109393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-coverage and cost-effective whole-genome sequencing assay for glioma risk stratification.
    Qin JJ; Xue F; Shen ZL; Chen XZ
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):8359-8367. PubMed ID: 37079053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancers.
    Kawauchi S; Furuya T; Ikemoto K; Nakao M; Yamamoto S; Oka M; Sasaki K
    Oncol Rep; 2010 Oct; 24(4):875-83. PubMed ID: 20811667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paradoxical relationship between chromosomal instability and survival outcome in cancer.
    Birkbak NJ; Eklund AC; Li Q; McClelland SE; Endesfelder D; Tan P; Tan IB; Richardson AL; Szallasi Z; Swanton C
    Cancer Res; 2011 May; 71(10):3447-52. PubMed ID: 21270108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantified CIN Score From Cell-free DNA as a Novel Noninvasive Predictor of Survival in Patients With Spinal Metastasis.
    Chen S; Yang M; Zhong N; Yu D; Jian J; Jiang D; Xiao Y; Wei W; Wang T; Lou Y; Zhou Z; Xu W; Wan W; Wu Z; Wei H; Liu T; Zhao J; Yang X; Xiao J
    Front Cell Dev Biol; 2021; 9():767340. PubMed ID: 34957099
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
    Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
    Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses.
    Vanderstichele A; Busschaert P; Smeets D; Landolfo C; Van Nieuwenhuysen E; Leunen K; Neven P; Amant F; Mahner S; Braicu EI; Zeilinger R; Coosemans A; Timmerman D; Lambrechts D; Vergote I
    Clin Cancer Res; 2017 May; 23(9):2223-2231. PubMed ID: 27852697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.